The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working...

Area of Science:

• Cardiology
• Cardiovascular Health
• Health Systems Management

Background:

• Major revisions to acute ST elevation myocardial infarction (STEMI) management guidelines by the American College of Cardiology/American Heart Association.
• Canadian Cardiovascular Society (CCS) involvement in guideline development and review.
• Formation of a Canadian Working Group (CWG) to adapt guidelines for the Canadian cardiovascular health system.

Purpose of the Study:

• Discuss implications of new STEMI guidelines for prehospital care, transport, and reperfusion therapy in Canada.
• Provide an approach to decision-making for reperfusion and invasive therapy post-fibrinolysis.
• Review indications and optimal timing for implantable cardioverter defibrillators (ICDs) post-STEMI, considering left ventricular function recovery.

Main Methods:

• Analysis of Canadian cardiovascular health system realities.
• Discussion of guideline implications for prehospital care, reperfusion strategies, and invasive therapy.
• Review of recent developments in implantable cardioverter defibrillator (ICD) indications and implantation timing.

Main Results:

• A recommended waiting period of at least 40 days, preferably 12 weeks, for evaluating left ventricular function post-STEMI before ICD implantation.
• Development of an algorithm for ICD insertion.
• Identification of substantial implications for healthcare resources, organization, and priorities in Canada.

Conclusions:

• Implementation of new STEMI guidelines necessitates significant healthcare system adjustments in Canada.
• Enhanced prehospital care, including early recognition, risk assessment, and fibrinolytic therapy, is crucial.
• Investment in tertiary/quaternary care, revascularization, and device implantation capabilities is important, but enhanced prehospital care is paramount for improving cardiac care.